Diabetes MellitusJohn A. Galloway, Janet H. Potvin, Charles R. Shuman Lilly Research Laboratories, 1988 - 335 pages |
From inside the book
Results 1-3 of 57
Page 113
... injected subcutaneously44,45,50 ( Table 7.3 ) . These factors are summarized below . Injection Site Following injection of regular insulin , the speed with which peak serum concentrations are reached varies with the anatomic site , as ...
... injected subcutaneously44,45,50 ( Table 7.3 ) . These factors are summarized below . Injection Site Following injection of regular insulin , the speed with which peak serum concentrations are reached varies with the anatomic site , as ...
Page 116
... injection in patients with diabetes with > 10 % binding by insulin antibodies , the rate of increase in free- insulin concentrations was diminished , the time of the peak serum insulin concentration was delayed , and the time to return ...
... injection in patients with diabetes with > 10 % binding by insulin antibodies , the rate of increase in free- insulin concentrations was diminished , the time of the peak serum insulin concentration was delayed , and the time to return ...
Page 176
... injection devices have also been developed . Each type is discussed below . Injection Devices Two forms of injection devices are available : electrically powered injection guns and the newer , more portable pen injectors . Insulin deliv ...
... injection devices have also been developed . Each type is discussed below . Injection Devices Two forms of injection devices are available : electrically powered injection guns and the newer , more portable pen injectors . Insulin deliv ...
Contents
Definition | 1 |
Chapter 2 iabetes Mellitus and Heredity | 15 |
Chapter 3 athophysiology of Diabetes Mellitus | 27 |
Copyright | |
15 other sections not shown
Common terms and phrases
abnormalities action activity agents antibodies associated betes blood glucose blood glucose concentrations body carbohydrate cause cells changes Chapter clinical complications continuous daily decrease determinations diabetes mellitus diabetic diet diabetic ketoacidosis diagnosis diet disease dose early effect exercise factors Figure given glucose tolerance glycemic glycosylated hemoglobin hormone human insulin hypoglycemia impaired important improved increased indicated individuals initial injection insulin infusion insulin receptor insulin resistance insulin secretion insulin therapy insulin-dependent levels lipoprotein liver meals measure metabolic methods mg/dl mmol/L monitoring muscle myocardial infarction needed normal obese occur oral patients with diabetes patients with Type plasma glucose pregnancy prevent production protein pump receptor reduced regular renal reported response retinopathy risk severe Source studies subcutaneous subjects Table therapy tion tissue treated treatment Type I diabetes Type II units urine usually values weight